PHARMION CORP (PHRM) is a publicly traded company in the Unknown sector. Across all available filings, 13 corporate insiders have executed 203 transactions totaling $34.3M, demonstrating a bullish sentiment with $23.7M in net insider flow. The most recent transaction on Mar 7, 2008 involved a transaction of 110,000 shares valued at $0.
No significant insider buying has been recorded for PHRM in the recent period.
No significant insider selling has been recorded for PHRM in the recent period.
Based on recent SEC filings, insider sentiment for PHRM is bullish with an Insider Alignment Score of 84/100 and a net flow of $23.7M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at PHARMION CORP (PHRM) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 13 insiders are actively trading PHRM stock, having executed 203 transactions in the past 90 days. The most active insider is James C. Blair (Executive), who has made 22 transactions totaling $27.8M.
Get notified when executives and directors at PHRM file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Mar 7, 2008 | J. Mckinley Edward | Executive | Disposition | 110,000 | $N/A | $0 | |
| Mar 7, 2008 | R. Allen Andrew | Executive | Option Exercise | 3,125 | $72.49 | $226.5K | |
| Mar 7, 2008 | R. Allen Andrew | Executive | Payment | 245 | $N/A | $0 | |
| Mar 7, 2008 | R. Allen Andrew | Executive | Option Exercise | 675 | $72.49 | $48.9K | |
| Mar 7, 2008 | R. Allen Andrew | Executive | Disposition | 3,793 | $N/A | $0 | |
| Mar 7, 2008 | T. Mast Erle | Executive | Option Exercise | 2,625 | $72.49 | $190.3K | |
| Mar 7, 2008 | T. Mast Erle | Executive | Payment | 816 | $N/A | $0 | |
| Mar 7, 2008 | T. Mast Erle | Executive | Disposition | 73,109 | $N/A | $0 | |
| Mar 7, 2008 | N. Dupont Steven | Executive | Payment | 513 | $N/A | $0 | |
| Mar 7, 2008 | N. Dupont Steven | Executive | Disposition | 4,267 | $N/A | $0 | |
| Mar 7, 2008 | N. Dupont Steven | Executive | Option Exercise | 1,650 | $72.49 | $119.6K | |
| Mar 7, 2008 | C. Ivers-read Gillian | Executive | Option Exercise | 2,100 | $72.49 | $152.2K | |
| Mar 7, 2008 | C. Ivers-read Gillian | Executive | Disposition | 46,040 | $N/A | $0 | |
| Mar 7, 2008 | C. Ivers-read Gillian | Executive | Payment | 653 | $N/A | $0 | |
| Mar 7, 2008 | J. Mahaffy Patrick | Executive | Disposition | 364,084 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 83 | $29.0M | 76.3% |
Sale(S) | 46 | $5.3M | 14.0% |
Exercise(M) | 32 | $3.5M | 9.3% |
Payment(F) | 15 | $140.3K | 0.4% |
Disposition(D) | 12 | $0 | 0.0% |
Other(J) | 15 | $0 | 0.0% |
Insiders at PHARMION CORP are accumulating shares at an accelerated pace. With 13 insiders making 203 transactions totaling $29.0M in purchases versus $5.3M in sales, the net buying activity of $23.7M signals strong executive confidence. James C. Blair (Executive) leads the buying activity with $27.8M in transactions across all time.